Kobayashi Pharmaceutical Co., Ltd.
KBYPF
Get informed when a big investor buys or sells
+ FollowMarket Cap$538.06B
Close$
Share Statistics
| Market cap | $538.06 Billion |
|---|---|
| Enterprise Value | $488.35 Billion |
| Dividend Yield | $0.66 (1.45%) |
| Earnings per Share | $49.19 |
| Beta | 0.25 |
| Outstanding Shares | 74,338,621 |
Return
| Return on Equity | 0.81% |
|---|---|
| Return on Assets | 0.67% |
| Return on Invested Capital | 5.63% |
Valuation & Multiples
| P/E Ratio | 330.96 |
|---|---|
| PEG | -353.96 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | 40.84 |
| Enterprise Value to Net Income | 290 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$230.22 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$0.42
Average shareholder expectationRevenue Estimate
$287.84 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kobayashi Pharmaceutical Co., Ltd.
3,731 employees
CEO: Norikazu Toyoda Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and international...